ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 80.72 USD -2.57% Market Closed
Market Cap: 1.8B USD

Wall Street
Price Targets

ANIP Price Targets Summary
ANI Pharmaceuticals Inc

Wall Street analysts forecast ANIP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANIP is 110.6 USD with a low forecast of 90.9 USD and a high forecast of 127.05 USD.

Lowest
Price Target
90.9 USD
13% Upside
Average
Price Target
110.6 USD
37% Upside
Highest
Price Target
127.05 USD
57% Upside
ANI Pharmaceuticals Inc Competitors:
Price Targets
DMP
Dermapharm Holding SE
14% Upside
KOTRA
Kotra Industries Bhd
21% Upside
OCS
Oculis Holding AG
121% Upside
NEULANDLAB
Neuland Laboratories Ltd
43% Upside
AJANTPHARM
Ajanta Pharma Ltd
16% Upside
PFIZER
Pfizer Ltd
25% Upside
000100
Yuhan Corp
23% Upside

Revenue
Forecast

Revenue Estimate
ANI Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 76%. The projected CAGR for the next 4 years is 16%.

76%
Past Growth
16%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
ANI Pharmaceuticals Inc

The compound annual growth rate of ANI Pharmaceuticals Inc's operating income for the next 4 years is 167%.

N/A
Past Growth
167%
Estimated Growth
Estimates Accuracy
-62%
Average Miss

Net Income
Forecast

Net Income Estimate
ANI Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANIP's stock price target?
Price Target
110.6 USD

According to Wall Street analysts, the average 1-year price target for ANIP is 110.6 USD with a low forecast of 90.9 USD and a high forecast of 127.05 USD.

What is ANI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 76%. The projected CAGR for the next 4 years is 16%.

What is ANI Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
167%

The compound annual growth rate of ANI Pharmaceuticals Inc's operating income for the next 4 years is 167%.

Back to Top